The dietary-stimulated levels of GLP-1 are reduced in T2DM, whereas the insulinotropic effects after infusion of pharmacological levels of GLP-1 are similar in people with diabetes and those who are euglycemic [17,18]. The gene discussed is GLP1R; the disease is diabetes mellitus.